- Correction
- Open access
- Published:
Correction to: Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis
Clinical Proteomics volume 20, Article number: 34 (2023)
The Original Article was published on 01 June 2020
Following publication of the original article [1], the authors noticed the errors in Fig. 4 and Supplementary Fig. 1.
In the Fig. 4, the CFHR5 band of G1-10 is duplicated with the C9 band.
In the Fig. 4 and Supplementary Fig. 1, the transferrin band of O6-10 is duplicated with the A6-10, independent sample O1-5.
In the Fig. 4 and Supplementary Fig. 1, the transferrin band of R6-10 is duplicated with the independent sample G1-5.
The corrected version of Fig. 4 is given below. The corrected supplementary file 5 is provided in this Correction article. The corrected figures do not alter the overall conclusions of this study, and all other data still stand. The authors regret this error and apologize for any confusion or inconvenience it may have caused.
Verification of C9, CFHR5, and MMP3 in synovial fluid by western blot. a Western blot analysis in the original synovial fluid sample set: A; AS (n = 10), R; RA (n = 10), G; gout (n = 10), and O; OA (n = 10). b Western blot analysis in the independent sample set: AS (n = 5), RA (n = 5), gout (n = 5), OA (n = 5). Transferrin was used as an input amount control
References
Lee JH, Jung JH, Kim JS, Baek WK, Rhee JS, Kim TH, et al. Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis. Clin Proteom. 2020;17:20.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12014-020-09281-y.
Electronic supplementary material
Below is the link to the electronic supplementary material.
12014_2023_9423_MOESM1_ESM.docx
Supplementary Material 1 S1. Verification of C4A, MBL2, and APCS in synovial fluid by western blot. (a) Western blot analysis in the original synovial fluid sample set: A; AS (n = 10), R; RA (n = 10), G; gout (n = 10), and O; OA (n = 10). (b) Western blot analysis in the Independent sample set: AS (n = 5), RA (n = 5), gout (n = 5), OA(n = 5). Transferrin was used as an input amount control.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Lee, JH., Jung, J.H., Kim, J. et al. Correction to: Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis. Clin Proteom 20, 34 (2023). https://doi.org/10.1186/s12014-023-09423-y
Published:
DOI: https://doi.org/10.1186/s12014-023-09423-y